APO Research
Talk to an analyst

APO RESEARCH · REPORT

Extracorporeal Membrane Oxygenation (ECMO) Systems

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

Selected research

Market Outlook & Growth Opportunities

Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchExtracorporeal Membrane Oxygenation (ECMO) Systems Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Extracorporeal Membrane Oxygenation (ECMO) Systems Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Extracorporeal Membrane Oxygenation (ECMO) Systems Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

The global extracorporeal membrane oxygenation (ECMO) system market is dominated by North America (41%) and Europe (34%). The market is growing due to improved patient safety and awareness among the doctors and patients. The Asian market is growing due to increasing adoption rate of ECMO machine in hospitals, success rate of ECMO & government initiatives, and growing awareness towards ECMO.

This market is segmented and forecast on the basis of modality, application and geography. The modality comprises of Veno Artrial (VA), Veno Venous (VV), the Veno Venous (VV) contributed to 61.82% of global market of ECMO system industry.

Read the full market overview

For China market, the industry is developing rapidly. The main players are Medtronic, Maquet, Sorin, Terumo and Xenios. Medtronic and Maquet enjoy more than 50% market share.

This report provides an overview of the global Extracorporeal Membrane Oxygenation (ECMO) Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Extracorporeal Membrane Oxygenation (ECMO) Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Extracorporeal Membrane Oxygenation (ECMO) Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Extracorporeal Membrane Oxygenation (ECMO) Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Company

Medtronic

Maquet

Sorin

Terumo

Xenios

Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Type

VA (Veno-Arterial) ECMO

VV (Veno-Venous) ECMO

Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Application

Neonatal

Pediatric

Adult

Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Extracorporeal Membrane Oxygenation (ECMO) Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Extracorporeal Membrane Oxygenation (ECMO) Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Extracorporeal Membrane Oxygenation (ECMO) Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Extracorporeal Membrane Oxygenation (ECMO) Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Extracorporeal Membrane Oxygenation (ECMO) Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Extracorporeal Membrane Oxygenation (ECMO) Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Extracorporeal Membrane Oxygenation (ECMO) Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Extracorporeal Membrane Oxygenation (ECMO) Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Extracorporeal Membrane Oxygenation (ECMO) Systems industry.

Chapter 3: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Extracorporeal Membrane Oxygenation (ECMO) Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Extracorporeal Membrane Oxygenation (ECMO) Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Trends Table 2. Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Drivers Table 3. Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Opportunities and Challenges Table 4. Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Restraints Table 5. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Company (2021-2026) Table 7. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Company (Units) & (2021-2026) Table 8. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Company (2021-2026) Table 9. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Average Price (K USD/Unit) of Company (2021-2026) Table 10. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company Ranking, (2024-2026) & (USD Million) Table 11. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Key Company Manufacturing Base & Headquarters Table 12. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company, Product Type & Application Table 13. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Extracorporeal Membrane Oxygenation (ECMO) Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of VA (Veno-Arterial) ECMO Table 18. Significant Companies of VV (Veno-Venous) ECMO Table 19. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Type (2021-2026) & (Units) Table 21. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Type (2027-2032) & (Units) Table 22. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Type (2021-2026) Table 23. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Type (2027-2032) Table 24. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type (2021-2026) Table 28. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Neonatal Table 30. Significant Companies of Pediatric Table 31. Significant Companies of Adult Table 32. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Application (2021-2026) & (Units) Table 34. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Application (2027-2032) & (Units) Table 35. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Application (2021-2026) Table 36. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Application (2027-2032) Table 37. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application (2021-2026) Table 41. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application (2027-2032) Table 42. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2021-2026) & (Units) Table 44. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Region (2021-2026) Table 45. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2027-2032) & (Units) Table 46. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Region (2027-2032) Table 47. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Region (2021-2026) Table 50. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Region (2027-2032) Table 52. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Average Price (K USD/Unit) by Region (2021-2026) Table 53. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Average Price (K USD/Unit) by Region (2027-2032) Table 54. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2026) & (Units) Table 57. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021-2026) Table 58. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2027-2032) & (Units) Table 59. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2027-2032) Table 60. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Market Share by Country (2021-2026) Table 62. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Market Share by Country (2027-2032) Table 64. Medtronic Company Information Table 65. Medtronic Business Overview Table 66. Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 67. Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 68. Medtronic Recent Development Table 69. Maquet Company Information Table 70. Maquet Business Overview Table 71. Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 72. Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 73. Maquet Recent Development Table 74. Sorin Company Information Table 75. Sorin Business Overview Table 76. Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 77. Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 78. Sorin Recent Development Table 79. Terumo Company Information Table 80. Terumo Business Overview Table 81. Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 82. Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 83. Terumo Recent Development Table 84. Xenios Company Information Table 85. Xenios Business Overview Table 86. Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 87. Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 88. Xenios Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Extracorporeal Membrane Oxygenation (ECMO) Systems Distributors List Table 92. Extracorporeal Membrane Oxygenation (ECMO) Systems Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Extracorporeal Membrane Oxygenation (ECMO) Systems Product Image Figure 2. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032) & (US$ Million) Figure 4. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (2021-2032) & (Units) Figure 5. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Average Price (K USD/Unit) & (2021-2032) Figure 6. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. VA (Veno-Arterial) ECMO Image Figure 10. VV (Veno-Venous) ECMO Image Figure 11. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Type (2021-2032) Figure 14. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type (2021-2032) Figure 17. Neonatal Image Figure 18. Pediatric Image Figure 19. Adult Image Figure 20. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Application (2021-2032) Figure 23. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application (2021-2032) Figure 26. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032) & (US$ Million) Figure 31. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032) & (US$ Million) Figure 37. South America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Extracorporeal Membrane Oxygenation (ECMO) Systems Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • VA (Veno-Arterial) ECMO
  • VV (Veno-Venous) ECMO
Applications
  • Neonatal
  • Pediatric
  • Adult
Companies covered
  • Medtronic
  • Maquet
  • Sorin
  • Terumo
  • Xenios

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032)
  4. 1.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume (2021-2032)
  5. 1.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Extracorporeal Membrane Oxygenation (ECMO) Systems Market Dynamics
  1. 2.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Trends
  2. 2.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Drivers
  3. 2.3 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Opportunities and Challenges
  4. 2.4 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Restraints
3 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Company
  1. 3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company Revenue Ranking in 2025
  2. 3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Company (2021-2026)
  3. 3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Company (2021-2026)
  4. 3.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Average Price by Company (2021-2026)
  5. 3.5 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company Ranking (2024-2026)
  6. 3.6 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company Manufacturing Base and Headquarters
  7. 3.7 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company Product Type and Application
  8. 3.8 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Extracorporeal Membrane Oxygenation (ECMO) Systems Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Type
  1. 4.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Type Introduction
  2. 4.1.1 VA (Veno-Arterial) ECMO
  3. 4.1.2 VV (Veno-Venous) ECMO
  4. 4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Type
  5. 4.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Type
  9. 4.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Type (2021-2032)
  11. 4.3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type (2021-2032)
5 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Application
  1. 5.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Application Introduction
  2. 5.1.1 Neonatal
  3. 5.1.2 Pediatric
  4. 5.1.3 Adult
  5. 5.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Application
  6. 5.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Application
  10. 5.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Application (2021-2032)
  12. 5.3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application (2021-2032)
6 Extracorporeal Membrane Oxygenation (ECMO) Systems Regional Sales and Value Analysis
  1. 6.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021-2026
  4. 6.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2027-2032)
  5. 6.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Region (2021-2032)
  7. 6.4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Region: 2021-2026
  8. 6.4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Region (2027-2032)
  9. 6.5 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032)
  12. 6.6.2 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032)
  15. 6.7.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032)
  21. 6.9.2 South America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Country, 2025 VS 2032
7 Extracorporeal Membrane Oxygenation (ECMO) Systems Country-level Sales and Value Analysis
  1. 7.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
  4. 7.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2026)
  5. 7.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2027-2032)
  6. 7.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Country (2021-2032)
  7. 7.4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Country (2021-2026)
  8. 7.4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Maquet
  8. 8.2.1 Maquet Company Information
  9. 8.2.2 Maquet Business Overview
  10. 8.2.3 Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  12. 8.2.5 Maquet Recent Developments
  13. 8.3 Sorin
  14. 8.3.1 Sorin Company Information
  15. 8.3.2 Sorin Business Overview
  16. 8.3.3 Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  18. 8.3.5 Sorin Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 Xenios
  26. 8.5.1 Xenios Company Information
  27. 8.5.2 Xenios Business Overview
  28. 8.5.3 Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  30. 8.5.5 Xenios Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Value Chain Analysis
  2. 9.1.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Mode & Process
  6. 9.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Distributors
  9. 9.2.3 Extracorporeal Membrane Oxygenation (ECMO) Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst